+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Urokinase plasminogen activator and its inhibitors in tissue extracts of planoepithelial lung cancer



Urokinase plasminogen activator and its inhibitors in tissue extracts of planoepithelial lung cancer



Fibrinolysis & Proteolysis 12(Suppl. 1): 94




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144154

Download citation: RISBibTeXText


Related references

Urokinase type plasminogen activator and its inhibitors in extracts of planoepithelial larynx cancer. Fibrinolysis & Proteolysis 12(Suppl. 1): 69, 1998

ELISA for complexes between urokinase-type plasminogen activator and its receptor in lung cancer tissue extracts. International Journal Of Cancer. 72(3): 416-423, 1997

The mRNA expression of urokinase-type plasminogen activator, its receptor and their inhibitors in primary lung cancer tissue. Fibrinolysis 10(Suppl. 3): 114, 1996

Gonadotropin surge-induced up-regulation of the plasminogen activators (tissue plasminogen activator and urokinase plasminogen activator) and the urokinase plasminogen activator receptor within bovine periovulatory follicular and luteal tissue. Biology of Reproduction 66(5): 1413-1421, 2002

Urokinase-type plasminogen activator and plasminogen activator inhibitors (PAI-1 and PAI-2) in extracts of invasive cervical carcinoma and precursor lesions. European Journal of Cancer 34(4): 566-569, 1998

Cancer cells overexpress mRNA of urokinase-type plasminogen activator, its receptor and inhibitors in human non-small-cell lung cancer tissue: analysis by Northern blotting and in situ hybridization. International Journal of Cancer 78(3): 286-292, 1998

Increased concentration of tissue plasminogen activator/plasminogen activator inhibitor type 1 complex and urokinase plasminogen activator in cytosols of early stage of malignant breast cancer. Blood 90(10 Suppl. 1 Part 2): 94B, Nov 15, 1997

Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue. Cancer Research 54(17): 4671-4675, 1994

Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis. Journal of Urology 174(2): 461-465, 2005

Urokinase-type plasminogen activator and plasminogen activator inhibitor antigen in tissue extracts of paranasal sinus mucous membranes affected by chronic sinusitis and antrochoanal polyps. European Archives of Oto-Rhino-Laryngology 256(5): 237-241, 1999

Urokinase-type plasminogen activator , urokinase-type plasminogen activator receptor , plasminogen activator inhibitor type 1 , type 2 , and tissue-type plasminogen activator in breast cancer cells. Fibrinolysis & Proteolysis 14(Suppl. 1): 38, 2000

Expression of tissue plasminogen activator, urokinase plasminogen activator, and urokinase plasminogen activator receptor on the lateral wall of the cochlea. Journal of the Osaka City Medical Center 56(1-2): 9-16, 2007

Detection of cathepsin B, cathepsin L, cystatin C, urokinase plasminogen activator and urokinase plasminogen activator receptor in the sera of lung cancer patients. Oncology Letters 2(4): 693-699, 2012